BAM Logo

HLA Diagnostics 05 – High resolution, molecular HLA typing class I and II (444)

[HLA-Diagnostik 05 - Hochauflösende, molekulargenetische HLA-Typisierung Klasse I und II (444)]

EPTIS factsheet 160009 | Last revision 2023-10-23 | URL: https://www.eptis.bam.de/pts160009 https://www.eptis.bam.de/pts160009

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of three reference institutions appointed by the German Medical Association and, thus, responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results as PDF via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors.
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
5 Samples of Leukocyte suspension (buffy coat), 1-1,5 ml each HLA-B 57:01 typing of DNA -
HLA-DRB1 typing of DNA (Shared Epitope) -
HLA-A typing of DNA (high resolution) -
HLA-B typing of DNA (high resolution) -
HLA-C typing of DNA (high resolution) -
HLA-DRB1 typing of DNA (high resolution) -
HLA-DRB 3/4/5 DNA-Typisierung (high resolution) -
HLA-DQA1 typing of DNA (high resolution) -
HLA-DQB1 typing of DNA (high resolution) -
HLA-DPB1 typing of DNA (high resolution) -
HLA-DPA1 typing of DNA (high resolution) -
Aims of the PT scheme
Target group of participants Molecular HLA typing class I and II in high resolution according to standards of the European Federation for Immunogenetics (EFI). The following loci may be reported: HLA-A,-B,-C,-DRB1,-DRB3/4/5,-DQA1,- DQB1,-DPA1 and -DPB1. In addition, HLA-B*57:01 associated with Abacavir hypersensitivity and HLA-DR epitopes associated with rheumatoid arthritis may be reported. It is not possible to report individual antigens, e.g. in the context of HLA disease associations (HLA-A29, HLA-B51, etc.)
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants <50
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee 140 Euro
Regularly operated Yes (4 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf

Phone: +49-211-159213-0
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430
Email: weiss@instand-ev.de weiss@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5